Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Redhill Biopharma Ltd (NASDAQ:RDHL)

14.88
Delayed Data
As of 3:59pm ET
 -0.53 / -3.44%
Today’s Change
6.89
Today|||52-Week Range
22.22
+11.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues22.9K16.0K12.0K6.9M
 
 
 
 
 
Cost of Goods Sold0.00----1.0M
 
 
Depreciation And Amortization14.9K24.0K24.1K26.6K
 
 
 
 
 
 
Operating ExpensesGross Income8.0K----5.9M
 
 
 
General Expenses7.9M9.0M10.8M16.5M
 
 
 
 
 
Research And Development5.4M6.5M8.1M12.5M
 
 
 
 
 
Total Operating Expenses7.9M9.1M10.8M17.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.8M-9.0M-10.8M-10.6M
 
 
 
 
 
Extraordinary Credit0.0057.0K54.1K197.2K
 
 
 
 
Extraordinary Charge-7.9M0.000.00--
 
 
Other Expenses306.8K-1.3M90.2K-279.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.4M-10.3M-10.7M-10.6M
 
 
 
 
 
Net Income-15.4M-10.3M-10.7M-10.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.8M5.3M6.2M8.7M
 
 
 
 
 
Shares To Calculate EPS Diluted4.8M5.3M6.2M8.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.19-$2.00-$1.70-$1.18
 
 
 
 
 
EPS Diluted-$3.19-$2.00-$1.70-$1.28